Q2 2022

Filed Feb 14, 2022 · 10-Q · 45 days after period end · 0000862668-22-000004

Q2 2022 · 10-Q

Revenue

$2.70M

−6.8% vs Q2 2021

Net Income

-$53.15K

N/M vs Q2 2021

EPS Diluted

-$0.01

N/M vs Q2 2021

Operating Income-$49,053N/M

Operating Cash Flow

Same quarter

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	$2.70M	$2.90M	$2.74M	$2.42M
Net Income	-$53.15K	$98.48K	-$675.34K	-$217.98K
EPS Diluted	-$0.01	$0.01	-$0.09	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR